The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating μ-opioid receptors

Pain

Volumn 145, Issue 1-2, 2009, Pages 219-229

  Pavone, Flaminia ^a   Luvisetto, Siro ^a   Marinelli, Sara ^a   Straface, Elisabetta ^b   Fabbri, Alessia ^b   Falzano, Loredana ^b   Fiorentini, Carla ^b   Malorni, Walter ^b  

^a CNR   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Opioid receptors; Bacterial protein toxins; Behavior; Cytoskeleton; Mice; Pain; Rho GTPases

Indexed keywords

ACTIN; CYSTEINE; CYTOTOXIC NECROTIZING FACTOR 1; FORMALDEHYDE; GUANOSINE TRIPHOSPHATASE; MU OPIATE RECEPTOR; NALOXONE; RAC PROTEIN; SERINE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MOUSE; NERVE CELL CULTURE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANALGESICS; ANIMALS; BACTERIAL TOXINS; CELL LINE, TUMOR; CEREBELLUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCHERICHIA COLI PROTEINS; FORMALDEHYDE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NALOXONE; NARCOTIC ANTAGONISTS; NEUROBLASTOMA; NF-KAPPA B; P21-ACTIVATED KINASES; PAIN; PAIN MEASUREMENT; RAC GTP-BINDING PROTEINS; RECEPTORS, OPIOID, MU; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 69049106353     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.06.026     Document Type: Article

References (44)

1. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
2. Baumhaker Y., Gafni M., Keren O., and Sarne Y. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol Pharmacol 44 (1993) 461-467
3. Bhave G., and Gereau R.W. Growing pains: the cytoskeleton as a critical regulator of pain plasticity. Neuron 39 (2003) 577-579
4. Borghi V., Przewlocka B., Labuz D., Maj M., Ilona O., and Pavone F. Formalin-induced pain and mu-opioid receptor density in brain and spinal cord are modulated by A1 and A2a adenosine agonists in mice. Brain Res 956 (2002) 339-348 [Erratum in: Brain Res 2003;981:217]
5. Boyer L., Travaglione S., Falzano L., Gauthier N.C., Popoff M.R., and Lemichez E. Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell 15 (2004) 1124-1133
6. Cahill C.M., Morinville A., Hoffert C., O'Donnell D., and Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101 (2003) 199-208
7. Chen Y.L., Law P.Y., and Loh H.H. Nuclear factor κB signaling in opioid functions and receptor gene expression. J Neuroimmune Pharmacol 1 (2006) 270-279
8. Chen Y.L., Law P.Y., and Loh H.H. Action of NF-kappaB on the delta opioid receptor gene promoter. Biochem Biophys Res Commun 352 (2007) 818-822
9. Diana G., Valentini G., Travaglione S., Falzano L., Pieri M., and Zona C. Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc Natl Acad Sci USA 104 (2007) 636-641
10. Dina O.A., McCarter G.C., de Coupade C., and Levine J.D. Role of the sensory neuron cytoskeleton in second messenger signaling for inflammatory pain. Neuron 39 (2003) 613-624
11. Dolly JO, Aoki KR. The structure and mode of action of different botulinum toxins. Eur J Neurol. 2006;Suppl. 4:1-9.
12. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
13. Falzano L., Fiorentini C., Donelli G., Michel E., Kocks C., and Cossart P. Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol 9 (1993) 1247-1254
14. Fiorentini C., Matarrese P., Straface E., Falzano L., Donelli G., and Boquet P. Rho-dependent cell spreading activated by E. coli cytotoxic necrotizing factor 1 hinders apoptosis in epithelial cells. Cell Death Differ 5 (1998) 921-929
15. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., and Fiorentini C. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387 (1997) 729-733
16. Frassdorf J., Weber N.C., Obal D., Toma O., Mullenheim J., and Kojda G. Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB. Anesth Analg 101 (2005) 934-941
17. Giamboi Miraglia A., Travaglione S., Meschini S., Falzano L., Matarrese P., and Quaranta M.G. Cytotoxic necrotizing factor 1 prevents apoptosis via the AKT/IKK pathway: role of NF-B and Bcl-2. Mol Biol Cell 18 (2007) 2735-2744
18. Goswami C., Dreger M., Otto H., Schwappach B., and Hucho F. Rapid disassembly of dynamic microtubules upon activation of the capsaicin receptor TRPV1. J Neurochem 96 (2006) 254-266
19. Jeynes L.C., and Gauci C.A. Evidence for the use of botulinum toxin in the chronic pain setting - a review of the literature. Pain Pract 8 (2008) 269-276
20. Kraus J., Borner C., Giannini E., and Hollt V. The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64 (2003) 876-884
21. Lewin G.R., and Moshourab R. Mechanosensation and pain. J Neurobiol 61 (2004) 30-44
22. Luvisetto S., Marinelli S., Lucchetti F., Marchi F., Cobianchi S., and Rossetto O. Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. Brain Res 1082 (2006) 124-131
23. Luvisetto S., Marinelli S., Panasiti M.S., D'Amato F.R., Fletcher C.F., and Pavone F. Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. Neuroscience 142 (2006) 823-832
24. Malorni W., Quaranta M.G., Straface E., Falzano L., Fabbri A., and Viora M. The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin/microtubule interplay. J Immunol 171 (2003) 4195-4202
25. Mannsfeldt A.G., Carroll P., Stucky C.L., and Lewin G.R. Stomatin, a MEC-2 like protein, is expressed by mammalian sensory neurons. Mol Cell Neurosci 13 (1999) 391-404
26. Mason P. Deconstructing endogenous pain modulations. J Neurophysiol 94 (2005) 1659-1663
27. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., and Kitchen I. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
28. Meffert M.K., and Baltimore D. Physiological functions for brain NF-kappaB. Trends Neurosci 28 (2005) 37-43
29. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
30. Narita M., Imai S., Narita M., Kasukawa A., Yajima Y., and Suzuki T. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception. Neuroscience 124 (2004) 515-521
31. Onoprishvili I., Andria M.L., Kramer H.K., Ancevska-Taneva N., Hiller J.M., and Simon E.J. Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. Mol Pharmacol 64 (2003) 1092-1100
32. Porro C.A., and Cavazzuti M. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog Neurobiol 41 (1993) 565-607
33. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
34. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., and Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387 (1997) 725-729
35. Schmidt G., Selzer J., Lerm M., and Aktories K. The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 273 (1998) 13669-13674
36. Stein C., Schafer M., and Machelska H. Attacking pain at its source. new perspectives on opioids. Nat Med 9 (2003) 1003-1008
37. Takayama N., and Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci 25 (2005) 430-435
38. Tatsumi S., Mabuchi T., Katano T., Matsumura S., Abe T., and Hidaka H. Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS). Neuroscience 131 (2005) 491-498
39. Travaglione S., Messina G., Fabbri A., Falzano L., Giammarioli A.M., and Grossi M. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases. Cell Death Differ 12 (2005) 78-86
40. Truong D.D., and Jost W.H. Botulinum toxin: clinical use. Parkinsonism Relat Disord 12 (2006) 331-355
41. Wu H.E., Hung K.C., Mizoguchi H., Nagase H., and Tseng L.F. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin. J Pharmacol Exp Ther 300 (2002) 647-654
42. Yang Y., Wilkening S., and Iadarola M.J. Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience 103 (2001) 493-502
43. Zhuang Z.Y., Xu H., Clapham D.E., and Ji R.R. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24 (2004) 8300-8309
44. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110